The Oxford-AstraZeneca Covid-19 vaccine produced by the Serum Institute of India. Photo: Agence France-Presse
The Oxford-AstraZeneca Covid-19 vaccine produced by the Serum Institute of India. Photo: Agence France-Presse

Will India’s Covishield export halt amid coronavirus surge hurt its vaccine diplomacy?

  • Officials have defended the decision to ‘calibrate’ Oxford/AstraZeneca vaccine exports made by the Serum Institute of India as the country experiences a second wave
  • But while production is being ramped up, the temporary halt in deliveries could affect Prime Minister Narendra Modi’s soft power efforts

The Oxford-AstraZeneca Covid-19 vaccine produced by the Serum Institute of India. Photo: Agence France-Presse
The Oxford-AstraZeneca Covid-19 vaccine produced by the Serum Institute of India. Photo: Agence France-Presse
READ FULL ARTICLE